Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), sold 16,194 shares at $23.75 ($385K) on 2023-02-10, disclosed to the SEC on 2023-02-15.
Open-market sale of $385k KDNY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.75 | 8,097 | $192K | 50.0% |
| 2 | $23.75 | 8,097 | $192K | 50.0% |
| Total | $23.75 avg | 16,194 | $385K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |
| KDNY | BUY | 2022-05-27 | $65K | — | Filing → |